Literature DB >> 8355250

Mono- and bis(aminomethyl)phenylacetic acid esters as short-acting antiarrhythmic agents. 2.

R J Chorvat1, L A Black, V V Ranade, C Barcelon-Yang, D M Stout, B S Brown, H F Stampfli, C Y Quon.   

Abstract

The synthesis, antiarrhythmic activity, and blood hydrolysis properties of a series of mono- and bis(aminomethyl)phenylacetic acid esters related to a previously reported class Ic antiarrhythmic agent (ACC-9358) are described. Of the various oxa-, aza-, thia-, and carbacyclic esters initially prepared in the bis(pyrrolidinomethyl)-4-hydroxyphenylacetic acid series, the 1,4-benzodioxanyl-2-methyl(3q) and the thienyl-2-methyl(31) esters were evaluated in vivo for antiarrhythmic efficacy. In addition, a number of monoappended phenylacetic esters of 3q with or without the 4-hydroxy group were also prepared for evaluation of antiarrhythmic, lipophilic, and metabolic properties. Of these compounds, 3q possessed the most desirable pharmacological and pharmacokinetic profile.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355250     DOI: 10.1021/jm00069a007

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Characterization of BU09059: a novel potent selective κ-receptor antagonist.

Authors:  Joseph J Casal-Dominguez; Daniel Furkert; Mehrnoosh Ostovar; Linnea Teintang; Mary J Clark; John R Traynor; Stephen M Husbands; Sarah J Bailey
Journal:  ACS Chem Neurosci       Date:  2014-01-28       Impact factor: 4.418

2.  Discovery of N-(3,5-bis(1-pyrrolidylmethyl)-4-hydroxybenzyl)-4-methoxybenzenesulfamide (sulcardine) as a novel anti-arrhythmic agent.

Authors:  Dong-Lu Bai; Wei-Zhou Chen; Yun-Xin Bo; Yue-Li Dong; Ai-Li Kang; Wei-Kang Sun; Wei Wang; Zhong-Liang Hu; Yi-Ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.